Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Thurs Jan 9th, the US Stock Markets will be closed in observance of a national day of mourning for former President Jimmy Carter. Read the press release here. Regular trading hours will resume tomorrow.

Dyne Therapeutics Inc (DYN)

Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,345,706
  • Shares Outstanding, K 101,766
  • Annual Sales, $ 0 K
  • Annual Income, $ -235,940 K
  • EBIT $ -314 M
  • EBITDA $ -314 M
  • 60-Month Beta 1.16
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.44

Options Overview Details

View History
  • Implied Volatility 180.95% ( +9.92%)
  • Historical Volatility 55.35%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 180.95% on 01/08/25
  • IV Low 39.80% on 06/18/24
  • Put/Call Vol Ratio 16.08
  • Today's Volume 666
  • Volume Avg (30-Day) 773
  • Put/Call OI Ratio 4.83
  • Today's Open Interest 15,567
  • Open Int (30-Day) 7,864

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.92
  • Number of Estimates 8
  • High Estimate -0.73
  • Low Estimate -1.08
  • Prior Year -1.09
  • Growth Rate Est. (year over year) +15.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.41 +2.86%
on 01/08/25
29.72 -22.43%
on 12/09/24
-6.45 (-21.86%)
since 12/06/24
3-Month
22.41 +2.86%
on 01/08/25
35.90 -35.79%
on 10/16/24
-10.08 (-30.43%)
since 10/08/24
52-Week
15.22 +51.50%
on 01/11/24
47.45 -51.42%
on 08/20/24
+5.02 (+27.84%)
since 01/08/24

Most Recent Stories

More News
Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

DYN : 23.05 (-3.35%)
Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET

DYN : 23.05 (-3.35%)
Insider Sale: Chief Scientific Officer of $DYN (DYN) Sells 2,334 Shares

Oxana Beskrovnaya, the Chief Scientific Officer of $DYN ($DYN), sold 2,334 shares of the company on 12-11-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately...

DYN : 23.05 (-3.35%)
Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

DYN : 23.05 (-3.35%)
Dyne Therapeutics to Present at Upcoming Investor Conferences

DYN : 23.05 (-3.35%)
Dyne Therapeutics Presents Data at World Muscle Society Congress Highlighting Promise of FORCE™ Platform to Address Underlying Causes of Neuromuscular Diseases

DYN : 23.05 (-3.35%)
2 Breakout Biotech Stocks With CEO Insider Buying

These two breakout stocks are on a stellar run higher on the charts, but should investors follow executives into the shares?

DYN : 23.05 (-3.35%)
RLMD : 0.4520 (-4.76%)
Chart of the Day: Dyne Therapeutics - Deeply Discounted

The Chart of the Day belongs to the biotechnology company Dyne Therapeutics (DYN) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals,...

DYN : 23.05 (-3.35%)
Why Shares of Dyne Therapeutics Fell This Week

Insiders sold more than 15,000 shares of company stock on Tuesday.

DYN : 23.05 (-3.35%)
Dyne Therapeutics Announces “Breakthrough Article” Publication of Duchenne Muscular Dystrophy Program Data in Nucleic Acids Research

- FORCE™ Platform Achieves Enhanced Exon Skipping and Prolonged Dystrophin Restoration in Duchenne in vivo mdx Model - WALTHAM, Mass., Aug. 10, 2022 ...

DYN : 23.05 (-3.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Dyne Therapeutics Inc. is a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The company's proprietary platform includes FORCE(TM). Dyne Therapeutics Inc. is based in WALTHAM, Mass.

See More

Key Turning Points

3rd Resistance Point 25.04
2nd Resistance Point 24.38
1st Resistance Point 23.72
Last Price 23.05
1st Support Level 22.40
2nd Support Level 21.74
3rd Support Level 21.08

See More

52-Week High 47.45
Fibonacci 61.8% 35.14
Fibonacci 50% 31.33
Fibonacci 38.2% 27.53
Last Price 23.05
52-Week Low 15.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar